Meniere's disease affects an estimated 0.2 per cent of the Australian population, which equates to roughly 40,000 to 50,000 people nationwide. Data from the Royal Victorian Eye and Ear Hospital, one of Australia's largest specialist ear clinics, confirms that Meniere's disease remains one of the most common referrals to its vestibular unit. The condition can develop at any age but most frequently begins between 40 and 60 years. It typically starts in one ear, with roughly 30 to 50 per cent of patients developing symptoms in both ears over time. Despite its prevalence, Meniere's disease is frequently misdiagnosed in its early stages because its hallmark symptoms overlap with several other conditions. Accurate diagnosis and early management are critical for preserving hearing and reducing the disruption that vertigo attacks cause to daily life. This article explains what Meniere's disease is, how it presents, what causes it, how clinicians diagnose it, and what treatment options are available.
What Is Meniere's Disease
Meniere's disease is a chronic inner ear disorder first described by the French physician Prosper Meniere in 1861. It is characterised by episodes of spontaneous vertigo, fluctuating hearing loss, tinnitus, and a sensation of fullness or pressure in the affected ear. These symptoms occur because of a condition called endolymphatic hydrops, which involves an abnormal buildup of endolymph fluid within the membranous labyrinth of the inner ear.
The inner ear contains two fluid-filled compartments. The perilymph surrounds the bony labyrinth, and the endolymph fills the membranous labyrinth inside it. In a healthy ear, the production and absorption of endolymph are balanced, maintaining stable pressure. In Meniere's disease, this balance is disrupted. Excess endolymph accumulates, causing the membranous structures, particularly the endolymphatic sac and the cochlear duct, to distend. This distension changes the pressure relationships within the inner ear and distorts the signals sent by both the vestibular system (which controls balance) and the cochlea (which controls hearing). The result is the characteristic pattern of vertigo accompanied by auditory symptoms that defines the disease.
It is important to note that endolymphatic hydrops can occur without Meniere's disease. Autopsy studies have found hydrops in people who never experienced symptoms. Meniere's disease is the clinical syndrome of recurrent vertigo plus auditory symptoms attributed to hydrops, not simply the presence of excess fluid alone.
The Four Classic Symptoms of Meniere's Disease
The American Academy of Otolaryngology Head and Neck Surgery defines definite Meniere's disease as two or more spontaneous episodes of vertigo lasting 20 minutes to 12 hours, plus audiometrically documented low- to mid-frequency sensorineural hearing loss in the affected ear, plus fluctuating aural symptoms such as hearing loss, tinnitus, or fullness. The four classic symptoms are described below.
Vertigo
Vertigo is the most disruptive symptom of Meniere's disease and the one that most often drives patients to seek medical attention. It is not simply dizziness. Vertigo is the false sensation that the environment is spinning or moving around you, or that you are spinning within a stationary environment. Attacks are typically rotational, come on without warning, and can be severe enough to cause nausea, vomiting, and inability to stand or walk. Each episode lasts between 20 minutes and several hours, distinguishing Meniere's vertigo from the brief seconds-long episodes of benign paroxysmal positional vertigo. Between attacks, most patients feel normal, though some experience persistent unsteadiness. The unpredictable nature of the episodes is one of the most difficult aspects of living with the condition.
Fluctuating Hearing Loss
Hearing loss in Meniere's disease characteristically affects the low frequencies first and fluctuates in the early stages. During or immediately after a vertigo attack, hearing may drop noticeably, then partially or fully recover once the episode resolves. Over months and years, this fluctuating pattern tends to give way to a permanent, progressive sensorineural hearing loss that can affect all frequencies. In the early stages, the shifting nature of the loss can make it difficult to detect on a single hearing test, which is why serial audiometry is essential for accurate diagnosis. The vertigo hearing loss connection in Meniere's disease is a defining clinical feature that separates it from other causes of vestibular episodes. Early identification and monitoring of this hearing loss by an audiologist can help track disease progression and guide treatment decisions.
Tinnitus
Tinnitus in Meniere's disease is typically described as a low-pitched roaring, humming, or buzzing sound in the affected ear. It often intensifies before or during a vertigo attack and may change in pitch or loudness as the disease fluctuates. For many patients, the tinnitus is present continuously at a low level and becomes more intrusive during episodes. As the disease progresses and permanent hearing loss develops, the tinnitus often becomes more persistent and may shift to higher frequencies. A dedicated tinnitus assessment can evaluate the characteristics of the sound and determine whether hearing aids with tinnitus masking features might provide relief.
Aural Fullness
Aural fullness is the sensation of pressure, blockage, or fullness in the affected ear. Many patients describe it as feeling like the ear needs to pop, similar to the sensation experienced during altitude changes, but without relief from yawning or swallowing. This symptom is thought to reflect the increased fluid pressure within the inner ear. Aural fullness often precedes a vertigo attack by hours or days, serving as a warning sign for some patients. It may worsen during an episode and subside afterwards, though in some individuals the pressure sensation remains constant.
Causes and Triggers of Meniere's Disease
The exact cause of endolymphatic hydrops in Meniere's disease remains unknown. Researchers have proposed several mechanisms, and the condition is likely multifactorial, meaning different factors contribute in different patients.
Anatomical Factors
Some studies have found that patients with Meniere's disease have smaller or less functional endolymphatic sacs and ducts compared to the general population. The endolymphatic sac is responsible for absorbing excess endolymph and regulating its pressure. When the sac is structurally compromised, fluid drainage may be impaired, leading to the accumulation that characterises hydrops. Genetic factors may influence this anatomical vulnerability, as Meniere's disease shows familial clustering in some cases, though no single gene has been definitively linked to the condition.
Allergic and Immune Mechanisms
A subset of patients with Meniere's disease report seasonal patterns to their attacks or co-existing allergies. Research published in JAMA Otolaryngology has found higher rates of autoimmune markers and allergy sensitivity in Meniere's patients compared to controls. The proposed mechanism is that allergic inflammation affects the endolymphatic sac via the same immune pathways that drive nasal and sinus congestion, impairing its fluid absorption function. Some patients benefit from allergy management as part of their overall treatment plan.
Known Triggers
While the underlying cause may be unclear, many patients identify consistent triggers that provoke or worsen their episodes. High dietary sodium intake is the most widely recognised trigger, as excess sodium increases fluid retention throughout the body, including within the inner ear. Caffeine and alcohol are also commonly reported triggers, possibly because of their effects on blood flow and fluid balance. Stress, fatigue, and poor sleep are associated with increased attack frequency. Changes in barometric pressure, such as those experienced during weather fronts or air travel, can provoke symptoms in some individuals. Keeping a detailed symptom diary that records diet, sleep, stress, and environmental conditions is one of the most practical steps patients can take to identify their personal triggers.
How Meniere's Disease Is Diagnosed
Diagnosing Meniere's disease requires a combination of clinical history, audiometric testing, and vestibular assessment. No single test confirms the diagnosis on its own. The process is one of matching the patient's symptom pattern to established diagnostic criteria while ruling out other conditions that can produce similar symptoms, such as vestibular migraine, acoustic neuroma, and autoimmune inner ear disease.
Audiometry
Pure-tone audiometry is the foundational test for evaluating hearing in suspected Meniere's disease. The characteristic finding is a sensorineural hearing loss affecting low frequencies (250 to 500 Hz) in the affected ear, particularly in early-stage disease. As the condition progresses, the hearing loss may flatten to involve mid and high frequencies. Because the hearing loss fluctuates, a single normal audiogram does not rule out the condition. Serial testing over several months provides the most reliable picture. Speech audiometry is also performed to assess how clearly speech is understood, which helps characterise the functional impact of the hearing loss.
Electrocochleography and VEMP Testing
Electrocochleography (ECoG) measures electrical potentials generated within the cochlea in response to sound. In Meniere's disease, the ratio between the summating potential and the action potential (SP/AP ratio) is typically elevated, reflecting the distension of the cochlear duct caused by endolymphatic hydrops. An SP/AP ratio greater than 0.5 is considered abnormal and supports the diagnosis. VEMP testing, which stands for vestibular evoked myogenic potential, assesses the function of the saccule, an inner ear structure sensitive to fluid pressure changes. Abnormal VEMP results, particularly reduced amplitude or elevated threshold in the affected ear, provide additional evidence of hydrops. These tests are often performed together as part of a comprehensive vestibular assessment.
Caloric Testing
Caloric testing evaluates the function of each lateral semicircular canal independently by introducing warm and cool water or air into each ear canal and measuring the resulting eye movements (nystagmus). The temperature change creates a convection current in the semicircular canal fluid, stimulating the vestibular nerve. In Meniere's disease, the affected ear may show reduced responsiveness (canal paresis) or, less commonly, hyperresponsiveness compared to the unaffected ear. Caloric testing is performed as part of videonystagmography or electronystagmography and helps quantify the degree of vestibular damage. Together with audiometry and ECoG, it builds a comprehensive clinical picture that supports or refutes the diagnosis of Meniere's disease.
Treatment and Management Options
There is no cure for Meniere's disease. Treatment focuses on reducing the frequency and severity of vertigo attacks, preserving hearing for as long as possible, and managing tinnitus and aural fullness. Management is typically approached in a stepwise fashion, starting with conservative measures and escalating to more invasive interventions only when symptoms remain uncontrolled.
Dietary and Lifestyle Modifications
Dietary sodium restriction is the most widely recommended first-line intervention. Most clinicians advise limiting sodium intake to 1,500 to 2,000 milligrams per day, which is below the Australian daily average of roughly 3,600 milligrams. Reducing sodium helps the body maintain better fluid balance, which may reduce the pressure buildup in the inner ear. Caffeine elimination or reduction is advised because caffeine can constrict blood vessels and potentially affect inner ear circulation. Alcohol should be moderated or avoided. Beyond diet, stress management through regular exercise, adequate sleep, and relaxation techniques such as mindfulness or deep breathing has been shown to reduce attack frequency in clinical studies. These conservative measures alone control symptoms adequately in roughly 60 to 70 per cent of patients.
Medications
Several medications are used in Meniere's disease management, each targeting a different aspect of the condition. Diuretics, most commonly hydrochlorothiazide or triamterene, are prescribed to reduce overall body fluid retention and are thought to decrease endolymph pressure. A randomised controlled trial published in the Archives of Otolaryngology found that diuretic therapy reduced vertigo frequency in the majority of participants. Betahistine, a medication widely used in Europe and Australia though not available in the United States, improves microcirculation in the inner ear and is prescribed to reduce vertigo attack frequency and severity. Vestibular suppressants such as prochlorperazine or promethazine are used during acute vertigo episodes to reduce nausea and the spinning sensation, though they are not intended for long-term daily use. Anti-anxiety medications may be prescribed when the unpredictability of attacks causes significant psychological distress.
Intratympanic Injections
When dietary changes and oral medications fail to control vertigo, the next step is often intratympanic injection. This involves delivering medication directly through the eardrum into the middle ear, where it diffuses into the inner ear at high concentration. Two agents are commonly used. Intratympanic dexamethasone reduces inflammation in the inner ear and can decrease vertigo attack frequency with a relatively low risk to hearing. Intratympanic gentamicin is an aminoglycoside antibiotic that is toxic to the vestibular hair cells. By selectively damaging the balance function in the affected ear, gentamicin effectively eliminates vertigo attacks in 80 to 90 per cent of patients. However, it carries a risk of additional hearing loss in the treated ear, estimated at 15 to 30 per cent of cases. The choice between dexamethasone and gentamicin depends on the severity of vertigo, the degree of remaining hearing, and patient preference after thorough counselling about the risks and benefits.
Surgical Options
Surgery is reserved for the small percentage of patients whose vertigo remains disabling despite maximal medical and injection therapy. Endolymphatic sac surgery aims to decompress the endolymphatic sac and improve fluid drainage. Results are variable, with some studies showing significant vertigo reduction and others showing outcomes similar to placebo. Vestibular nerve section involves cutting the balance nerve while preserving the hearing nerve, eliminating the aberrant vestibular signals that cause vertigo while protecting remaining hearing. This procedure has a high success rate for vertigo control but carries the risks associated with craniotomy. Labyrinthectomy removes the entire labyrinth of the affected ear, eliminating vertigo in nearly all cases but also destroying all residual hearing in that ear. It is reserved for patients who already have profound hearing loss and severe, uncontrolled vertigo. The decision to proceed with any surgical intervention requires detailed discussion with an otologist or neurotologist about the expected benefits, risks, and impact on quality of life.
Hearing Rehabilitation
As Meniere's disease progresses, permanent hearing loss in the affected ear is common. Hearing rehabilitation should be initiated early and adjusted as hearing changes. For mild to moderate losses, conventional hearing aids can amplify speech and environmental sounds effectively. For severe to profound unilateral losses where a traditional hearing aid provides insufficient benefit, CROS (contralateral routing of signal) hearing aids or bone-anchored hearing devices may be recommended. These devices transmit sound from the deaf ear to the better-hearing ear, restoring awareness of sounds from the affected side. Regular audiometric monitoring ensures that the rehabilitation strategy keeps pace with the disease progression.
Frequently Asked Questions
Can Meniere's disease go away on its own?
Meniere's disease does not have a cure, but the frequency and severity of attacks often decrease over time. Research suggests that after eight to ten years of living with the condition, many patients experience fewer vertigo episodes. However, the hearing loss and tinnitus associated with Meniere's disease tend to persist and may worsen progressively. Active management through dietary modifications, medication, and professional monitoring can significantly reduce symptom impact and slow the progression of hearing damage.
What triggers a Meniere's disease attack?
Common triggers for Meniere's disease attacks include high sodium intake, caffeine, alcohol, stress, fatigue, allergies, and changes in barometric pressure. Many patients find that consuming more than 1,500 to 2,000 milligrams of sodium per day increases the likelihood of an episode. Keeping a symptom diary that tracks diet, sleep, stress levels, and weather changes can help identify individual triggers. Avoiding known triggers is one of the most effective ways to reduce attack frequency.
Is Meniere's disease classed as a disability in Australia?
Meniere's disease can be recognised as a disability under Australian law when it substantially impacts a person's ability to work, communicate, or perform daily activities. Eligibility for support through the National Disability Insurance Scheme depends on the severity and permanence of functional impairment. Patients whose vertigo attacks are frequent and unpredictable, or whose hearing loss significantly limits communication, may qualify. A treating specialist can provide documentation to support an application.
How is Meniere's disease different from BPPV?
Meniere's disease and benign paroxysmal positional vertigo both cause vertigo but have different underlying mechanisms. BPPV occurs when calcium carbonate crystals become dislodged in the inner ear canals, triggering brief episodes of vertigo lasting seconds to minutes, typically brought on by specific head movements. Meniere's disease involves abnormal fluid pressure in the inner ear and produces vertigo attacks lasting twenty minutes to several hours, accompanied by fluctuating hearing loss, tinnitus, and ear fullness. BPPV does not cause hearing loss. A vestibular assessment can distinguish between the two conditions.
Works Cited
Lopez-Escamez, Jose A., et al. "Diagnostic Criteria for Meniere's Disease." Journal of Vestibular Research, vol. 25, no. 1, 2015, pp. 1-7.
Hain, Timothy C., and Peter C. Helminski. "Anatomy and Physiology of the Normal Vestibular System." Vestibular Rehabilitation, edited by Susan J. Herdman, 4th ed., F.A. Davis, 2014, pp. 2-24.
Thirlwall, Anne S., and S. Surenthiran. "Betahistine in the Treatment of Meniere's Disease." Expert Opinion on Pharmacotherapy, vol. 4, no. 11, 2003, pp. 2001-2007.
Adrion, C., et al. "Efficacy and Safety of Betahistine Treatment in Patients with Meniere's Disease: Meta-Analysis of Randomized Controlled Trials." PLOS ONE, vol. 15, no. 9, 2020, e0238597.
Hu, Amy, and P. Ashley Wackym. "Intratympanic Steroid Therapy for Meniere's Disease." Otology and Neurotology, vol. 37, no. 1, 2016, pp. 31-37.
Perez, R., et al. "Intratympanic Gentamicin for the Treatment of Meniere's Disease: A Meta-Analysis." Otology and Neurotology, vol. 35, no. 9, 2014, pp. 1573-1580.
Chow, Yuen F., et al. "Quality of Life in Meniere's Disease: A Systematic Review." Journal of Laryngology and Otology, vol. 134, no. 7, 2020, pp. 582-588.
Royal Victorian Eye and Ear Hospital. "Vestibular Disorders and Meniere's Disease." RVEEH, Melbourne, 2023, eyeandear.org.au.